GLP-1 Therapies and Muscle Health: What Dietitians Need to Know
Incretin-based therapies can produce substantial weight loss, but changes in fat-free tissue and skeletal muscle raise important questions about nutrition, resistance exercise, functional health and interpretation of body-composition data.
Watch the webinar on the original host
This recording is hosted by the original publisher and is not available for embedded playback on 7PRIME because of the video's privacy settings.
Watch Original WebinarWhy this topic matters.
Focus
The presentation reviews changes in body composition during incretin-based therapy and discusses how those findings should be interpreted given limitations of commonly used body-composition methods.
Applied themes
Nutrition assessment, adequate protein and energy intake, resistance exercise, and monitoring of muscle health are central practical themes.
Higher-risk populations
The session also considers individuals who may be more vulnerable to muscle loss and the role of dietitians within interdisciplinary obesity care.
Carla M. Prado, PhD, RD, FCAHS
Dr. Prado is a Distinguished University Professor at the University of Alberta and a Tier 1 Canada Research Chair in Integrative Nutrition, Body Composition, and Energy Metabolism. Her work focuses on clinical nutrition and body composition, including muscle health across aging, obesity and chronic disease.
External webinar, original source retained.
This page is an educational index and viewing interface. Ownership and presentation rights remain with the original publisher and video host.